Form 4: Director Volkart Boosts MODD Stake

Modular Medical Director Carmen B Volkart plans to acquire 3,125 shares of common stock on December 31, 2025, increasing her direct beneficial ownership to 21,460 shares.

Summary

• Carmen B Volkart, a Director of Modular Medical, Inc. (MODD), is scheduled to acquire 3,125 shares of the company's common stock.
• This acquisition is planned for December 31, 2025, and is being made pursuant to the Issuer's Outside Director Compensation Plan.
• Following this planned transaction, Ms. Volkart's direct beneficial ownership of Modular Medical, Inc. common stock will total 21,460 shares.
• The transaction is being made under a Rule 10b5-1 plan, indicating a pre-arranged purchase of equity securities.

Sentiment

Score: 6

Explanation: The planned acquisition of shares by a director, even if part of a compensation plan, is generally viewed as a mildly positive signal, indicating continued alignment of interests and confidence in the company's future.

Positives

• A Director's planned acquisition of additional shares, even as part of a compensation plan, can signal continued confidence in the company's future prospects and align management interests with shareholders.

Future Outlook

The filing outlines a planned future acquisition of 3,125 shares of common stock by Director Carmen B Volkart on December 31, 2025, under the company's Outside Director Compensation Plan. This transaction is pre-arranged under a Rule 10b5-1 plan.

Industry Context

This is a routine insider transaction filing, common across all industries, where directors receive or acquire company stock as part of their compensation or through pre-arranged trading plans. It does not provide specific insights into broader industry trends or competitive landscape.

Related Party Transactions

• The acquisition of shares by Director Carmen B Volkart is pursuant to the Issuer's Outside Director Compensation Plan, which constitutes a form of related party transaction (compensation to a director).

Stakeholder Impact

• Shareholders may view the planned increase in director ownership as a positive signal, suggesting management's continued commitment and belief in the company's value.

Next Steps

• The planned acquisition of 3,125 shares of common stock by Director Carmen B Volkart is scheduled to occur on December 31, 2025.

Key Dates

Recommendation

This Form 4 filing details a planned, routine compensation-related stock acquisition by a director under a 10b5-1 plan. While insider buying can be a positive signal, this specific transaction, being a compensation grant rather than an open market purchase, and relatively small in scale, does not provide sufficient new information to warrant a change from a 'hold' recommendation. It primarily confirms ongoing director compensation practices.

Keywords

Modular Medical, MODD, Carmen B Volkart, Director, Stock Acquisition, Insider Transaction, Form 4, Compensation Plan, 10b5-1 Plan